TRansferring Analytical Cancer-detection Expertise across Systems
The status, timeline and source of this project. A free account opens every field.
Source: EU Funding & Tenders Portal
Several research groups have developed distinct analytical methods for detecting cancer earlier using routine primary care data, including platelet-based risk markers (Exeter), blood test trajectory modelling (Oxford/BLOTTED), diagnostic interval measurement (Aarhus/CaP), and machine learning risk stratification (Karolinska/STEADY-CAN). These methods have been developed largely in parallel, on dif
- Status
- Prospective
- Sector
- Education
- Location
- Ireland, Sweden, Denmark, United Kingdom
- Updated
- 19 Nov 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about TRansferring Analytical Cancer-detection Expertise across Systems
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Several research groups have developed distinct analytical methods for detecting cancer earlier using routine primary care data, including platelet-based risk markers (Exeter), blood test trajectory modelling (Oxford/BLOTTED), diagnostic interval measurement (Aarhus/CaP), and machine learning risk stratification (Karolinska/STEADY-CAN). These methods have been developed largely in parallel, on different national datasets, within different health systems. No systematic attempt has been made to test whether signals identified by one method replicate when applied in a different system. TRACES (TRansferring Analytical Cancer-detection Expertise across Systems) addresses this gap through structured researcher mobility. By moving people, not patient data, across a consortium spanning seven countries and two sectors, TRACES will produce the first systematic cross-validation of early cancer detection methods across health systems. Secondments will transfer established methods to new datasets, identify which pre-diagnostic signals are robust across systems and which are local artefacts, and determine the minimum data maturity required before each method becomes deployable. The key output is a Data Readiness Framework specifying which methods work in which data environments, directly informing national implementation decisions. The consortium comprises 6 beneficiaries and 3 associated partners across Ireland, the UK, Sweden, Denmark, South Africa, Australia, and Singapore. RCSI (Ireland) coordinates. The non-academic partner (Centric Health) leads translation of outputs into clinical practice through GP-facing usability evaluation of risk stratification tools. The project runs for 48 months with 260 person-months of staff exchanges. Beyond the funded period, TRACES will continue as a sustained research cooperative embedded within the Ca-PRI (Cancer in Primary Care) international network, ensuring long-term methodological alignment and cross-system learning. |
Location
Country | Ireland, Sweden, Denmark, United Kingdom |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Education |
Article published date | 2026-10-15 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
